Want to join the conversation?
Emerging markets revenue for $BDX grew 5.9% on currency-neutral basis in 4Q15, bringing YTD growth to 9.2%. The 4Q15 growth rate in emerging markets reflects some moderation in China and Brazil. China growth for 4Q15 was 8.5%, bringing the total year growth to 15.4%. $BDX expects emerging markets revenue to grow at about 10% in fiscal year 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?